Major Triple Antibiotic is a Topical Ointment in the Human Otc Drug category. It is labeled and distributed by Major Pharmaceuticals. The primary component is Polymyxin B Sulfate; Neomycin Sulfate; Bacitracin Zinc.
| Product ID | 0904-8805_a6cb0006-17c3-28e2-e053-2995a90adc98 |
| NDC | 0904-8805 |
| Product Type | Human Otc Drug |
| Proprietary Name | Major Triple Antibiotic |
| Generic Name | Bacitracin Zinc, Neomycin, Polymyxin B Sulfat |
| Dosage Form | Ointment |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2020-04-20 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part333B |
| Labeler Name | Major Pharmaceuticals |
| Substance Name | POLYMYXIN B SULFATE; NEOMYCIN SULFATE; BACITRACIN ZINC |
| Active Ingredient Strength | 5000 [USP'U]/g; mg/g; [USP'U]/g |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-05-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph final |
| Application Number | part333B |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2020-05-29 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0904-6680 | Major Triple Antibiotic | Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate |
| 0904-8805 | Major Triple Antibiotic | Bacitracin Zinc, Neomycin, Polymyxin B Sulfat |